Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Recent & Breaking News (NDAQ:APHA)

Data Shows Strong Demand for Medical Cannabis Products

PR Newswire December 27, 2017

Data Shows the Demand for Legal Cannabis Products are Expected to Grow

PR Newswire December 22, 2017

Green Giants of the Future - The Biggest Winners Of Canada's Cannabis Boom

PR Newswire December 21, 2017

Aphria Strengthens Leadership Position in Recreational Cannabis with $10 Million Investment in Toyko Smoke-DOJA Combination

Canada NewsWire December 21, 2017

Aphria Inc. Announces $100 Million Bought Deal

MarketWire Canada December 13, 2017

Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At VirtualInvestorConferences.com

PR Newswire December 11, 2017

S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices

Canada NewsWire December 8, 2017

IIROC Trade Resumption - APH

Canada NewsWire December 4, 2017

IIROC Trading Halt - APH

Canada NewsWire December 4, 2017

IIROC Trade Resumption - Aphria Inc.

Newsfile December 4, 2017

Aphria enters into supplier agreement with Shoppers Drug Mart

Canada NewsWire December 4, 2017

IIROC Trade Halt - Aphria Inc.

Newsfile December 4, 2017

Aphria Achieves Next Milestone in International Expansion Strategy with Receipt of Dealer's License

Canada NewsWire November 23, 2017

Aphria Announces Closing of Bought Deal Financing

Canada NewsWire November 7, 2017

Shareholders elect Renah Persofsky and Shawn Dym to Aphria's Board of Directors

Canada NewsWire October 27, 2017

Aphria Completes First Medical Cannabis Oil (CBD/THC) Shipment to Australia-based Medlab

Canada NewsWire October 24, 2017

Aphria engages in positive dialogue with Toronto Stock Exchange

Canada NewsWire October 23, 2017

Aphria Inc. Announces $80 Million Bought Deal

MarketWire Canada October 17, 2017

Aphria welcomes new CSA disclosure guidelines, provides comment on TSX staff notice

Canada NewsWire October 17, 2017

Investing In Marijuana: Cannabis Industry Raises Hit $1.8 Billion, Up 150% Year Over Year

Benzinga.com  October 16, 2017